Ipeleng Kgosiemang-Xaba | Oncology | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Ipeleng Kgosiemang-Xaba
University of the Free State, South Africa
Ipeleng Kgosiemang-Xaba
Affiliation University of the Free State
Country South Africa
Scopus ID 56707418000
Documents 9
Citations 241
h-index 7
Subject Area Oncology
Event Health Scientists Awards

Ipeleng Kgosiemang-Xaba is presented in this academic recognition profile as a researcher associated with oncology and biomedical research at the University of the Free State in South Africa. Her scholarly work includes investigations of Euphorbia species, phytochemicals, antiproliferative activity, nanomaterials, and cancer-related applications. Publications identify research examining plant-derived compounds, toxicity, pharmacological properties, and nanoparticle-based approaches against breast cancer models. This work connects natural-product research with experimental oncology and drug-discovery questions.[1]

Abstract

Ipeleng Kgosiemang-Xaba is presented in this recognition profile as a researcher associated with oncology and biomedical research at the University of the Free State in South Africa. Her scholarly work includes investigations of Euphorbia species, phytochemicals, antiproliferative activity, nanomaterials, and cancer-related applications. Publications identify research examining plant-derived compounds, toxicity, pharmacological properties, and nanoparticle-based approaches against breast cancer models. This work connects natural-product research with experimental oncology and drug-discovery questions. The profile therefore highlights an interdisciplinary trajectory centered on biologically active South African plants, cancer-related mechanisms, and translational opportunities while maintaining a neutral distinction between documented scientific outputs and award recognition.[3]

Keywords

Euphorbia species; cancer; medicinal plants; pharmacological properties; toxicity; secondary metabolites; breast cancer; antiproliferative activity; iron oxide nanoparticles; iron dioxide nanoparticles; natural-product pharmacology; phytochemicals. These terms are aligned particularly with the publication literature addressing Southern African Euphorbia species and experimental anticancer research.[2]

Introduction

Ipeleng Kgosiemang-Xaba’s research profile reflects an interdisciplinary interest in oncology, medicinal plants, pharmacology, and biomedical technology. Her publications address Euphorbia-derived bioactive compounds and experimental anticancer approaches, including nanoparticle systems evaluated against breast cancer cell lines. These themes place natural-product research within a framework of cancer research and translational biomedical investigation.[1]

Research Profile

Ipeleng Kgosiemang-Xaba has published work spanning molecular biology, medicinal plants, phytochemistry, pharmacology, and oncology. Her research includes studies of Euphorbia species and their secondary metabolites, together with experimental investigations of antiproliferative effects and nanoparticle-mediated approaches. The available literature indicates a continuing interest in linking biological resources with therapeutic research questions.[2][3]

Research Contributions

Ipeleng Kgosiemang-Xaba’s contributions include systematic examination of Southern African Euphorbia species, their medicinal uses, toxicity, phytochemical constituents, and reported pharmacological activities. Her research also includes green synthesis of iron-based nanoparticles using Euphorbia tirucalli and evaluation of antiproliferative activity against breast cancer cell lines, thereby connecting plant science with experimental oncology.[2][3]

Publications

Ipeleng Kgosiemang-Xaba is associated with publications addressing Euphorbia pharmacology, anticancer research, nanoparticle synthesis, and molecular biology. A 2025 review in Plants examined medicinal uses, toxicity, secondary metabolites, and pharmacological properties of Southern African Euphorbia species, while a 2023 Journal of Experimental Nanoscience article evaluated iron-based nanoparticles and breast cancer models.[5]

Research Impact

Ipeleng Kgosiemang-Xaba’s research impact can be considered through the relevance of her publications to natural-product pharmacology, cancer biology, and biomedical nanotechnology. Her work contributes evidence on underexplored Southern African plant resources and experimental anticancer strategies. Citation activity and publication visibility provide measurable indicators, while broader clinical significance requires further validation.[3]

Award Suitability

Ipeleng Kgosiemang-Xaba’s documented research themes are compatible with an Innovative Research Award focused on oncology, natural-product discovery, and biomedical technology. Her publications demonstrate research activity involving anticancer constituents, Euphorbia species, phytochemicals, and nanoparticle systems. Award suitability should remain subject to the event’s published formal criteria, independent verification, and comparative assessment.[4]

Conclusion

Ipeleng Kgosiemang-Xaba presents a research profile connecting Southern African medicinal plants with pharmacology, nanotechnology, and oncology. Her publications provide evidence of work on Euphorbia chemistry, toxicity, antiproliferative activity, and cancer-oriented experimental systems. Collectively, these outputs support recognition of an emerging interdisciplinary research direction without implying clinical efficacy beyond published evidence.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Ipeleng Kgosiemang-Xaba, Author ID 56707418000. Scopus.https://www.scopus.com/authid/detail.uri?authorId=56707418000
  2. Kgosiemang, I. K. R., Lefojane, R., Adegoke, A. M., Ogunyemi, O., Mashele, S. S., & Sekhoacha, M. P. (2025). Pharmacological significance, medicinal use, and toxicity of extracted and isolated compounds from Euphorbia species found in Southern Africa: A review. Plants, 14(3), 469.https://doi.org/10.3390/plants14030469
  3. Kgosiemang, I. K. R., Adegoke, A. M., Mashele, S. S., & Sekhoacha, M. P. (2023). Green synthesis of iron oxide and iron dioxide nanoparticles using Euphorbia tirucalli: Characterization and antiproliferative evaluation against three breast cancer cell lines. Journal of Experimental Nanoscience, 18(1), 2276276.https://doi.org/10.1080/17458080.2023.2276276
  4. Parvez, M., Qhanya, L. B., Mthakathi, N. T., Kgosiemang, I. K. R., et al. (2016). Molecular evolutionary dynamics of cytochrome P450 monooxygenases across kingdoms: Special focus on mycobacterial P450s. Scientific Reports, 6, 33099.https://doi.org/10.1038/srep33099
  5. Kgosiemang, I. K. R. (2024). Targeted delivery of iron, cobalt and magnesium nanoparticles incorporating anticancer constituents of Euphorbia species for treatment of breast cancer. Doctor of Health Sciences in Biomedical Technology, Central University of Technology, Free State.https://cutscholar.cut.ac.za/items/e527142e-a8dc-4c94-8eb1-121facf1eff7/full

Thurayya Eid | Mental Health | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Thurayya Eid — King Saud University, Saudi Arabia

Thurayya Eid
Affiliation King Saud University
Country Saudi Arabia
Scopus ID 24764600600
Documents 23
Citations 87
h-index 4
Subject Area Mental Health
Event Health Scientists Awards
ORCID 0000-0003-3613-1099

Thurayya Eid is a researcher and nursing academic affiliated with King Saud University whose scholarly work addresses clinical nursing practice, patient safety, pain management, healthcare quality, and experiences of patients and healthcare professionals in Saudi Arabia. Her publication record includes observational, qualitative, clinical, and evidence-based research relevant to contemporary health sciences. [1]

Abstract

Thurayya Eid is a nursing researcher at King Saud University whose scholarly work examines clinical practice, patient safety, pain management, medication processes, healthcare quality, and patient and professional experiences. Her publications address evidence-based postoperative care, nurses’ clinical decision-making, medication-work interruptions, hospital performance, and contemporary healthcare experiences in Saudi Arabia. Recent collaborative studies extend this work toward family-centered care, palliative care, maternal health, resilience, professional support, and nursing practice. Collectively, these contributions demonstrate an applied research profile connecting clinical evidence, healthcare delivery, nursing practice, and patient outcomes. Her work provides relevant perspectives for recognition within health sciences and mental health-related research contexts.[4]

Keywords

Postoperative pain management; nursing clinical decision-making; medication-work interruptions; patient safety; evidence-based nursing; hospital performance; healthcare quality; nursing leadership; palliative care; family-centered care; maternal health; nursing students; supervisory support; nurse burnout; resilience; oncology nursing; Saudi Arabia; clinical nursing practice; patient outcomes; mental health.[5]

Introduction

Thurayya Eid has developed a scholarly profile centered on nursing practice and healthcare delivery, with research addressing medication processes, pain assessment, clinical decisions, and quality improvement. Her institutional profile identifies her as an Assistant Professor at King Saud University, while published studies demonstrate sustained engagement with applied clinical research. [1]

Research Profile

Thurayya Eid maintains a research profile spanning medical-surgical nursing, patient safety, pain management, clinical decision-making, and healthcare quality. Her work combines observational, qualitative, and evidence-based approaches to examine practical challenges affecting nurses and patients. This orientation connects nursing scholarship with measurable improvements in clinical processes and healthcare experiences. [2]

Research Contributions

Thurayya Eid has contributed research concerning postoperative pain management, nurses’ knowledge and attitudes toward pain, clinical decision-making, medication-work interruptions, and organizational healthcare performance. More recent collaborative publications broaden the scope toward family-centered care, palliative experiences, maternal health, resilience, professional support, and nursing education, illustrating an evolving applied research agenda. [3]

Publications

Thurayya Eid has published research including work on evidence-based postoperative pain management in older patients with hip fractures, nurses’ clinical decision-making, pain knowledge and attitudes, medication-work interruptions, and hospital performance. Her later collaborative work includes family-centered pediatric care, palliative care experiences, maternal sleep, and supervisory support among nursing students. [1]

Research Impact

Thurayya Eid demonstrates research impact through studies addressing practical issues in nursing and healthcare delivery, particularly patient safety, pain management, medication processes, and quality of care. Her publications also contribute evidence concerning professional experiences and patient-centered services in Saudi Arabia, supporting discussion of evidence-based nursing and healthcare improvement. [2]

Award Suitability

Thurayya Eid presents a research record relevant to an Innovative Research Award through sustained scholarly engagement with clinical nursing, patient safety, healthcare quality, and evidence-based practice. Her documented publications provide a basis for evaluating originality, practical relevance, methodological contribution, and influence within health sciences, subject to the award’s formal assessment criteria and verification procedures.[4]

Conclusion

Thurayya Eid has established an applied academic profile in nursing and health research through publications addressing clinical practice, patient safety, pain management, medication processes, and healthcare experiences. Her collaborative research extends these interests across patient-centered and professional contexts, providing a scholarly foundation for consideration in recognition programs focused on research innovation and healthcare advancement.

References

  1. King Saud University. (n.d.). Thurayya Eid: Faculty profile and publications. King Saud University.
    https://faculty.ksu.edu.sa/en/teid
  2. Eid, T., Machudo, S., & Eid, R. (2022). Interruptions during medication work in a Saudi Arabian hospital: An observational and interview study of nurses. https://doi.org/10.1111/jnu.12765
  3. Eid, T., Manias, E., Bucknall, T., & Almazrooa, A. (2014). Nurses’ knowledge and attitudes regarding pain in Saudi Arabia. Pain Management Nursing.
    https://faculty.ksu.edu.sa/sites/default/files/eidmaniasbucknallmazroa_2014.pdf
  4. Google Scholar. (n.d.). Publication and Citation Profile of Thurayya Eid.
    https://scholar.google.com/citations?user=ixXIPcQAAAAJ&hl=en&oi=ao
  5. Eid, T., Alshaibany, F. F., Alodhailah, A. M., & Alshehri, W. M. (2026). Exploring the relationship between supervisory support, self-efficacy, and satisfaction among nursing students in Saudi Arabia. PLoS ONE, 21(7). DOI: https://doi.org/10.1371/journal.pone.0352318

Bernd Fink | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Bernd Fink
Affiliation Orthopaedic Clinic Markgröningen
Country Germany
Scopus ID 22943409800
Documents 176
Citations 3,339
h-index 29
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-7485-3941
Bernd Fink – Orthopaedic Clinic Markgröningen, Germany

Bernd Fink is a German orthopaedic surgeon and clinical researcher whose scholarly work primarily focuses on hip and knee arthroplasty, implant fixation, revision surgery, prosthetic joint infection, and long-term orthopedic outcomes. His scientific publications have contributed to improving evidence-based clinical practice through investigations into implant performance, surgical techniques, and patient-centered treatment strategies. His academic profile reflects sustained engagement with musculoskeletal research and international collaboration within clinical medicine.[1]

Abstract

Bernd Fink has established an internationally recognized academic profile through clinical investigations involving hip arthroplasty, knee replacement, implant fixation, revision procedures, prosthetic joint infection, biomaterials, and orthopedic outcomes. His publications emphasize evidence-based surgical decision-making, implant longevity, patient safety, and postoperative functional recovery. By integrating clinical observations with long-term follow-up studies, his research supports improvements in orthopedic practice and healthcare quality. His contributions continue influencing musculoskeletal surgery through scientifically validated findings that benefit clinicians, researchers, and patients while strengthening international orthopedic literature and advancing modern clinical medicine through collaborative multidisciplinary research worldwide.[2]

Keywords

Hip Arthroplasty, Knee Arthroplasty, Revision Arthroplasty, Prosthetic Joint Infection, Cementless Implant, Implant Fixation, Acetabular Cup, Femoral Stem, Orthopaedic Surgery, Clinical Outcomes, Total Hip Replacement, Joint Reconstruction.

Introduction

Bernd Fink investigates orthopedic surgery through clinically relevant research addressing joint replacement, revision strategies, implant fixation, infection prevention, and long-term patient outcomes. His scholarly publications integrate practical surgical experience with scientific evaluation, supporting evidence-based improvements in musculoskeletal healthcare while strengthening contemporary orthopedic knowledge through internationally recognized clinical investigations.[1]

Research Profile

Bernd Fink maintains an active research profile centered on hip arthroplasty, knee replacement surgery, prosthetic joint infection, implant survival, revision procedures, and orthopedic biomechanics. His publications demonstrate sustained collaboration with international researchers while contributing valuable clinical evidence supporting safer surgical interventions and improved patient rehabilitation across orthopedic practice.[2]

Research Contributions

Bernd Fink contributes significantly by evaluating implant performance, optimizing revision arthroplasty techniques, investigating prosthetic infections, and improving postoperative recovery through evidence-based orthopedic studies. His findings assist clinicians in selecting effective surgical approaches while promoting durable implant performance and enhanced quality of patient-centered musculoskeletal healthcare internationally.[3]

Publications

Bernd Fink has published extensively on hip arthroplasty, knee replacement, prosthetic joint infection, implant fixation, revision surgery, and long-term orthopedic outcomes. His scholarly articles emphasize evidence-based surgical practice, implant longevity, patient recovery, and clinical decision-making, providing valuable scientific knowledge that supports continuous advancements in modern orthopedic medicine worldwide.[3]

Research Impact

Bernd Fink’s research provides clinically meaningful evidence supporting orthopedic surgeons managing complex arthroplasty cases. His publications strengthen understanding of implant longevity, revision surgery, prosthetic infection prevention, and postoperative rehabilitation. These scholarly contributions continue supporting healthcare professionals seeking reliable evidence for improving orthopedic surgical quality and patient outcomes.[4]

Award Suitability

Bernd Fink demonstrates qualities consistent with recognition through the Innovative Research Award because his sustained orthopedic investigations have strengthened evidence-based clinical medicine. His scholarly contributions, publication record, international visibility, and commitment to improving arthroplasty outcomes collectively reflect meaningful scientific achievement deserving academic recognition within contemporary health sciences.[4]

Conclusion

Bernd Fink continues contributing valuable scientific knowledge through orthopedic clinical research emphasizing implant performance, revision surgery, infection management, and patient outcomes. His publications support evidence-based healthcare while promoting continuous improvements in musculoskeletal medicine. His academic achievements illustrate a sustained commitment to advancing clinical medicine through rigorous scientific investigation.[2]

References

  1. Scopus Author Profile. Bernd Fink.
    https://www.scopus.com/authid/detail.uri?authorId=22943409800
  2. ORCID. Bernd Fink Research Profile.
    https://orcid.org/0000-0002-7485-3941
  3. Fink, B., & Tetsworth, K. D. (2017). Antibiotic elution from cement spacers and its influencing factors.
    https://doi.org/10.3390/antibiotics14070705
  4. ResearchGate Profile.
    https://www.researchgate.net/profile/Bernd-Fink-3
  5. Health Scientists Awards.
    https://healthscientists.org/

Sarfaraz Niazi | Clinical Medicine | Lifetime Achievement Award

Published on by Health Scientists

Lifetime Achievement Award

Sarfaraz Niazi
Affiliation Washington State University
Country United States
Scopus ID 7004749563
Documents 156
Citations
2,572
h-index 26
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-0513-0336

Sarfaraz Niazi
Washington State University, United States

Sarfaraz Niazi is an internationally recognized pharmaceutical scientist whose scholarly work has significantly influenced pharmaceutical formulation science, manufacturing technologies, dosage form development, drug delivery systems, regulatory sciences, and pharmaceutical product commercialization. His publications, technical handbooks, and scientific contributions have been extensively utilized by academic researchers, pharmaceutical industries, regulatory professionals, and healthcare innovators worldwide. His sustained research productivity, educational publications, and practical innovations demonstrate long-term contributions to clinical medicine and pharmaceutical sciences deserving scholarly recognition.[1]

Abstract

Sarfaraz Niazi has established a distinguished academic career through influential research, authoritative pharmaceutical reference books, and practical innovations supporting drug formulation, pharmaceutical manufacturing, analytical development, quality assurance, and commercialization. His scholarly publications have contributed to improving pharmaceutical education, industrial manufacturing practices, regulatory understanding, and formulation science across diverse healthcare applications. The breadth of his scientific output, sustained international citation record, and educational influence demonstrate enduring contributions to clinical medicine and pharmaceutical sciences while supporting innovation, professional training, and evidence-based pharmaceutical development worldwide.[2]

Keywords

Pharmaceutical formulation, Drug delivery, Pharmaceutical manufacturing, Dosage forms, Preformulation, Drug development, Regulatory science, Clinical medicine, Pharmaceutical technology, Quality assurance, Drug discovery, Formulation development.

Introduction

Sarfaraz Niazi has contributed extensively to pharmaceutical sciences through multidisciplinary research integrating formulation development, manufacturing technologies, analytical methodologies, and industrial pharmaceutical practice. His scientific publications and reference books continue supporting researchers, educators, pharmaceutical manufacturers, and healthcare professionals seeking evidence-based approaches for modern pharmaceutical product development and commercialization.[3]

Research Profile

Sarfaraz Niazi has maintained an internationally recognized scholarly profile characterized by influential publications, comprehensive pharmaceutical textbooks, industrial expertise, and sustained academic engagement. His research spans pharmaceutical manufacturing, formulation optimization, regulatory sciences, dosage form technologies, and translational pharmaceutical innovation supporting healthcare advancement through scientific excellence.[1]

Research Contributions

Sarfaraz Niazi has advanced pharmaceutical sciences by developing authoritative resources addressing formulation strategies, manufacturing processes, quality systems, and commercialization pathways. His publications bridge academic knowledge with industrial implementation, strengthening pharmaceutical education while facilitating innovation in drug development, product quality, and therapeutic manufacturing technologies worldwide.[4]

Publications

Sarfaraz Niazi has authored influential books and peer-reviewed publications covering pharmaceutical preformulation, liquid dosage manufacturing, computer-aided drug discovery, pharmaceutical technologies, and industrial formulation sciences. These scholarly resources remain widely referenced within universities, pharmaceutical industries, regulatory organizations, and professional research environments internationally.[5]

Research Impact

Sarfaraz Niazi has generated enduring academic and industrial influence through publications supporting pharmaceutical innovation, formulation optimization, manufacturing quality, and educational advancement. His scholarly contributions continue assisting researchers and healthcare industries in developing effective pharmaceutical products while strengthening evidence-based pharmaceutical sciences internationally.[2]

Award Suitability

Sarfaraz Niazi demonstrates sustained scholarly excellence through influential research publications, internationally recognized pharmaceutical references, educational leadership, and practical industrial innovation. These long-term scientific achievements, combined with substantial global academic influence, strongly align with the objectives and recognition standards associated with the Lifetime Achievement Award.[1]

Conclusion

Sarfaraz Niazi has built an internationally respected scientific legacy through pharmaceutical research, industrial innovation, educational scholarship, and authoritative publications. His lasting influence across pharmaceutical sciences, clinical medicine, formulation technology, and healthcare education reflects the sustained excellence expected from recipients of distinguished international scientific recognition.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Sarfaraz Niazi, Author ID 7004749563. Scopus.
    https://www.scopus.com/pages/authors/7004749563
  2. ORCID. (n.d.). Sarfaraz Niazi ORCID Record.
    https://orcid.org/0000-0002-0513-0336
  3. Google Scholar. (n.d.). Scholar Profile: Sarfaraz Niazi.
    https://scholar.google.com/citations?user=O2dgTYIAAAAJ&hl=en&oi=ao
  4. ResearchGate. (n.d.). Sarfaraz Niazi Research Profile.
    https://www.researchgate.net/profile/Sarfaraz-Niazi-3
  5. Niazi, S. K., & Mariam, Z. (2024). Computer-aided Drug Design and Drug Discovery: A Prospective Analysis. Pharmaceuticals.
    https://doi.org/10.3390/ph17010022

Aimaz Afrough | Oncology | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Aimaz Afrough
UT Southwestern Medical Center, United States

Aimaz Afrough
Affiliation UT Southwestern Medical Center
Country United States
Scopus ID 43660943000
Documents 63
Citations 1,171
h-index 19
Subject Area Oncology
Event Health Scientists Awards
ORCID 0000-0003-2645-8557

Aimaz Afrough is a researcher affiliated with UT Southwestern Medical Center whose scholarly work primarily focuses on oncology, molecular cancer biology, translational medicine, and clinically relevant cancer investigations. The research portfolio reflects sustained contributions to understanding tumor biology, improving diagnostic approaches, and supporting evidence-based therapeutic development. Publications indexed in major scientific databases demonstrate active participation in multidisciplinary cancer research while promoting scientific collaboration and clinical translation within contemporary oncology research.[1]

Abstract

Aimaz Afrough investigates oncology through multidisciplinary research integrating molecular biology, translational medicine, cancer diagnostics, and therapeutic innovation. Published studies emphasize clinically meaningful discoveries that improve understanding of tumor development, disease progression, biomarker identification, and treatment response. The research demonstrates collaboration across biomedical disciplines while supporting evidence-based clinical practice and precision oncology. Scientific publications indexed in recognized databases contribute to advancing cancer research, strengthening translational applications, encouraging interdisciplinary collaboration, and providing valuable knowledge that informs future investigations, patient-centered healthcare strategies, and sustainable improvements in oncology outcomes worldwide.[2]

Keywords

Oncology, Cancer Biology, Tumor Microenvironment, Precision Oncology, Molecular Oncology, Cancer Biomarkers, Translational Medicine, Immuno-Oncology, Clinical Oncology, Cancer Therapeutics

Introduction

Aimaz Afrough contributes to oncology research by investigating biological mechanisms underlying cancer and translating laboratory discoveries into clinically meaningful knowledge. Research activities strengthen interdisciplinary collaboration while supporting innovative diagnostic methods, precision medicine, and therapeutic development that improve understanding of complex malignancies across diverse healthcare environments.[3]

Research Profile

Aimaz Afrough maintains an academic profile centered on oncology, emphasizing molecular mechanisms, translational investigations, biomarker discovery, and collaborative biomedical research. Publications demonstrate commitment to scientific rigor while addressing clinically relevant questions that support evidence generation and continuous advancement of modern cancer research and healthcare innovation.[1]

Research Contributions

Aimaz Afrough has contributed to collaborative investigations exploring cancer biology, translational oncology, molecular diagnostics, and therapeutic strategies. Research findings enhance scientific understanding of disease mechanisms while supporting precision medicine initiatives, improving clinical interpretation, and encouraging continued innovation across multidisciplinary oncology research communities worldwide.[4]

Publications

Aimaz Afrough has authored and coauthored peer-reviewed publications indexed within recognized scientific databases. Published studies address oncology, molecular medicine, and translational research while reflecting sustained scholarly engagement, interdisciplinary collaboration, methodological quality, and contributions supporting scientific communication, clinical relevance, and future biomedical investigation.[2]

Research Impact

Aimaz Afrough demonstrates measurable research impact through scholarly publications, scientific collaborations, and dissemination within oncology. The research supports evidence-based medicine, encourages knowledge exchange, informs future investigations, and contributes valuable insights that strengthen translational cancer research and broader biomedical scientific advancement internationally.[1]

Award Suitability

Aimaz Afrough demonstrates qualifications appropriate for consideration within the Innovative Research Award through consistent oncology research, interdisciplinary collaboration, scholarly publications, and contributions supporting translational medicine. Scientific activities reflect innovation, academic integrity, and continuing commitment to advancing biomedical knowledge through evidence-based cancer research.[5]

Conclusion

Aimaz Afrough continues contributing to oncology through collaborative scientific research emphasizing translational relevance, molecular discoveries, and clinical applicability. Continued scholarly activities strengthen biomedical knowledge, encourage innovation, support evidence-based healthcare, and provide meaningful foundations for future advances within international oncology research communities.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Aimaz Afrough, Author ID 43660943000. Scopus.
    https://www.scopus.com/pages/authors/43660943000
  2. ORCID. (n.d.). Aimaz Afrough ORCID Record.
    https://orcid.org/0000-0003-2645-8557
  3. Google Scholar. (n.d.). Scholar Profile: Aimaz Afrough.
    https://scholar.google.com/citations?user=2ENlGnkAAAAJ&hl=en&oi=ao
  4. ResearchGate. (n.d.). Aimaz Afrough Research Profile.
    https://www.researchgate.net/profile/Aimaz-Afrough
  5. Health Scientists Awards. (n.d.). Innovative Research Award.
    https://healthscientists.org/

Murtaza Khan | Genomics | Best Academic Researcher Award

Published on by Health Scientists

Best Academic Researcher Award

Murtaza Khan
Affiliation Kangwon National University
Country South Korea
Scopus ID 57207990116
Documents 52
Citations 1,789
h-index 23
Subject Area Infectious Diseases
Event Health Scientists Awards
ORCID 0000-0001-8431-8451

Murtaza Khan is affiliated with Kangwon National University, South Korea, where research activities primarily focus on infectious diseases, microbial pathogenesis, antimicrobial resistance, and translational biomedical science. His publication record, citation performance, and international research visibility demonstrate sustained academic productivity within infectious disease research and related biomedical disciplines.[1]

Abstract

Murtaza Khan has established a consistent academic profile through investigations addressing infectious diseases, microbial interactions, antimicrobial resistance, molecular diagnostics, and translational biomedical science. His publications contribute to understanding disease mechanisms while encouraging evidence-based therapeutic strategies and improved public health outcomes. Supported by a substantial citation record and internationally indexed publications, his research reflects interdisciplinary collaboration and scientific relevance. The documented scholarly output demonstrates sustained productivity, methodological rigor, and meaningful contributions to infectious disease research, providing valuable knowledge for clinicians, microbiologists, epidemiologists, and healthcare researchers across global scientific communities.[1][2]

Keywords

Infectious Diseases, Antimicrobial Resistance, Clinical Microbiology, Molecular Diagnostics, Bacterial Pathogenesis, Host–Pathogen Interaction, Antimicrobial Peptides, Drug Resistance, Public Health Microbiology, Translational Medicine, Biomedical Research, Emerging Pathogens.

Introduction

Murtaza Khan advances infectious disease research through multidisciplinary investigations integrating microbiology, molecular biology, and translational medicine. His studies improve scientific understanding of pathogen behavior, antimicrobial resistance, and therapeutic innovation while supporting evidence-based healthcare practices through internationally recognized scholarly publications and collaborative academic research.[1]

Research Profile

Murtaza Khan maintains an established research profile characterized by peer-reviewed publications, significant citation performance, and international collaborations. His scholarly activities emphasize infectious diseases, microbial pathogenesis, diagnostic technologies, and biomedical innovation, contributing measurable scientific value across clinical microbiology and translational health research disciplines.[3]

Research Contributions

Murtaza Khan contributes to infectious disease science by investigating microbial mechanisms, antimicrobial resistance, pathogen-host interactions, and innovative therapeutic strategies. His collaborative research supports improved disease diagnosis, treatment development, and biomedical knowledge while strengthening international scientific literature within microbiology and infectious disease investigations.[2]

Publications

Murtaza Khan has authored numerous peer-reviewed publications indexed within international databases. His research articles address infectious diseases, molecular microbiology, antimicrobial resistance, diagnostics, and translational medicine, reflecting sustained scholarly productivity while supporting evidence-based scientific advancement through quality publications and interdisciplinary collaboration.[4]

Research Impact

Murtaza Khan demonstrates measurable research impact through fifty-two indexed publications, 1,789 citations, and an h-index of twenty-three. These indicators reflect broad scholarly recognition, consistent citation influence, and meaningful contributions supporting continued scientific progress within infectious diseases and biomedical research communities.[1]

Award Suitability

Murtaza Khan demonstrates qualifications appropriate for the Best Academic Researcher Award through sustained publication productivity, recognized citation performance, interdisciplinary collaboration, and internationally visible research addressing infectious diseases. These achievements align with academic excellence, scientific innovation, and impactful biomedical scholarship evaluation standards.[1]

Conclusion

Murtaza Khan represents an accomplished researcher whose scholarly achievements contribute meaningfully to infectious disease science. His publication record, citation influence, and collaborative investigations demonstrate sustained academic excellence while supporting future biomedical discoveries, evidence-based healthcare improvements, and international scientific advancement through continued research activities.[1]

External Links

References

    1. Elsevier. (n.d.). Scopus author details: Murtaza Khan, Author ID 57207990116. Scopus.
      https://www.scopus.com/pages/authors/57207990116
    2. ORCID. (n.d.). Murtaza Khan ORCID record.
      https://orcid.org/0000-0001-8431-8451
    3. Google Scholar. (n.d.). Scholar profile of Murtaza Khan.
      https://scholar.google.com/citations?user=QlVZ0QQAAAAJ&hl=en&oi=ao
    4. ResearchGate. (n.d.). Murtaza Khan ResearchGate profile.
      https://www.researchgate.net/profile/Murtaza-Khan

Haider Qasim | Infectious Diseases | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Haider Qasim
Queensland University of Technology, Australia

Haider Qasim
Affiliation Queensland University of Technology
Country Australia
Subject Area Infectious Diseases
Event Health Scientists Awards
ORCID 0000-0002-7929-6451

Haider Qasim is affiliated with Queensland University of Technology, Australia, where his scholarly activities contribute to infectious diseases research through interdisciplinary investigations, evidence-based methodologies, and collaborative scientific initiatives. His publications emphasize disease surveillance, antimicrobial resistance, epidemiological analysis, clinical microbiology, and public health applications that support improved healthcare outcomes. This article summarizes his research profile, scientific contributions, publication themes, research impact, and suitability for recognition through the Innovative Research Award within the Health Scientists Awards program.[1]

Abstract

Haider Qasim investigates infectious diseases through multidisciplinary research integrating microbiology, epidemiology, molecular diagnostics, antimicrobial resistance, and public health perspectives. His publications emphasize evidence-based clinical applications, disease surveillance, healthcare improvement, and collaborative scientific innovation. By combining laboratory findings with epidemiological interpretation, his work supports informed decision-making for infection prevention and control while advancing healthcare practices. The collective research demonstrates sustained academic engagement, scientific rigor, and practical relevance, contributing valuable knowledge to infectious disease management and strengthening the global understanding of emerging pathogens, healthcare-associated infections, and antimicrobial stewardship initiatives.[2]

Keywords

Antimicrobial Resistance, Infectious Diseases, Clinical Microbiology, Molecular Diagnostics, Epidemiology, Public Health, Disease Surveillance, Bacterial Pathogens, Healthcare-Associated Infections, Infection Prevention, Emerging Pathogens, Microbial Genomics.

Introduction

Haider Qasim focuses on infectious diseases by integrating microbiological investigation with epidemiological analysis to understand pathogen behavior and healthcare challenges. His research supports evidence-driven medical practice, encourages interdisciplinary collaboration, and strengthens scientific knowledge for disease prevention, diagnosis, treatment strategies, and sustainable improvements in public health systems worldwide.[3]

Research Profile

Haider Qasim maintains an active academic profile through scholarly publications, collaborative investigations, and contributions addressing infectious disease management. His work reflects consistent engagement with clinically relevant research themes, emphasizing laboratory science, microbial characterization, epidemiological interpretation, and translational approaches that benefit healthcare research communities internationally.[1]

Research Contributions

Haider Qasim contributes to infectious disease science by investigating microbial pathogens, antimicrobial resistance mechanisms, molecular diagnostic applications, and infection control practices. His studies encourage scientific collaboration while supporting improved healthcare decisions through reliable evidence, methodological rigor, and clinically meaningful research outcomes across diverse medical environments.[2]

Publications

Haider Qasim has contributed publications addressing infectious diseases, microbial diagnostics, epidemiological investigations, antimicrobial resistance, and healthcare improvement. His scholarly outputs demonstrate scientific consistency while supporting knowledge dissemination through peer-reviewed literature that advances understanding of infection prevention, clinical microbiology, and evidence-based healthcare practices globally.[4]

Research Impact

Haider Qasim’s research enhances scientific understanding of infectious diseases through clinically relevant investigations and collaborative scholarship. His contributions support healthcare professionals, researchers, and policymakers by providing evidence applicable to disease surveillance, antimicrobial stewardship, infection prevention, and improved public health practices across international research environments.[1]

Award Suitability

Haider Qasim demonstrates qualities aligned with the Innovative Research Award through sustained scholarly activity, interdisciplinary collaboration, publication excellence, and meaningful contributions to infectious diseases research. His academic profile reflects scientific integrity, practical healthcare relevance, and continued advancement of evidence-based knowledge supporting international scientific development.[5]

Conclusion

Haider Qasim has established a research profile centered on infectious diseases through publications, interdisciplinary collaboration, and clinically relevant investigations. His scholarly contributions strengthen scientific knowledge while supporting healthcare innovation, evidence-based decision-making, and continued advancement of infectious disease research within the global academic and medical communities.[2]

External Links

References

  1. Logan, P., Jones, R., Gabe-Walters, M., Qasim, H., & Jordan, S. (n.d.). Strategising to identify preventable adverse drug reactions in rural and regional aging populations of Australia. https://researchoutput.csu.edu.au/en/publications/strategising-to-identify-preventable-adverse-drug-reactions-in-ru/
  2. ORCID. (n.d.). Haider Qasim – ORCID Record.
    https://orcid.org/0000-0002-7929-6451
  3. Qasim, H., Simpson, M., Guisard, Y., & de Courten, B. (2020). A comprehensive evaluation of studies on the adverse effects of medications in Australian aged care facilities: A scoping review.
    https://doi.org/10.3390/pharmacy8020056
  4. Qasim, H., & Lu, Y. (2026). Systematic evaluation framework for ML and DL-based ransomware detection.
    https://www.preprints.org/manuscript/202602.2011
  5. Health Scientists Awards. Innovative Research Award.
    https://healthscientists.org/

Said Moshawih | Pharmacology | Best Researcher Award

Published on by Health Scientists
Said Moshawih
Affiliation Al-Ahliyya Amman University
Country Jordan
Scopus ID 57209745538
Documents 42
Citations 998
h-index
17
Subject Area Pharmacology
Event Health Scientists Awards
ORCID 0000-0003-4840-0460

Best Researcher Award

Said Moshawih is an academic researcher specializing in pharmacology, medicinal plants, natural products, phytochemistry, pharmaceutical sciences, and evidence-based herbal medicine. His research integrates laboratory investigations with systematic scientific reviews to evaluate bioactive compounds, therapeutic mechanisms, and translational healthcare applications. His scholarly publications have contributed to understanding herbal pharmacology, cardiovascular protection, antimicrobial activities, antioxidant mechanisms, and functional medicinal plants while supporting innovation in pharmaceutical research and healthcare advancement.[1]

Abstract

Said Moshawih has established an internationally recognized research portfolio in pharmacology through multidisciplinary investigations involving medicinal plants, phytochemistry, pharmaceutical sciences, cardiovascular health, antimicrobial agents, antioxidant compounds, and evidence-based herbal medicine. His publications emphasize translating traditional medicinal knowledge into scientifically validated therapeutic applications while encouraging sustainable healthcare innovation. Through collaborations, systematic reviews, experimental pharmacology, and natural product research, his work has strengthened pharmaceutical development, improved understanding of bioactive compounds, supported clinical relevance, and contributed valuable scientific evidence for advancing modern healthcare practices and future pharmacological discoveries.[2]

Keywords

Medicinal plants, Pharmacology, Phytochemistry, Herbal medicine, Natural products, Antioxidants, Cardiovascular health, Antimicrobial activity, Ethnopharmacology, Functional foods, Bioactive compounds, Pharmaceutical sciences, Toxicology, Drug discovery, Plant extracts.

Introduction

Said Moshawih investigates medicinal plants and pharmaceutical sciences by integrating pharmacological evidence with phytochemical characterization. His research supports safe therapeutic development, explores natural bioactive compounds, and promotes evidence-based herbal medicine for improving disease prevention, healthcare quality, and future pharmaceutical innovation through multidisciplinary scientific collaboration worldwide.[3]

Research Profile

Said Moshawih maintains an active international research profile with publications spanning pharmacology, medicinal chemistry, pharmaceutical technology, herbal therapeutics, and systematic scientific reviews. His collaborative investigations have generated influential literature supporting translational medicine while encouraging innovation across academic, clinical, and pharmaceutical research environments globally.[1]

Research Contributions

Said Moshawih has contributed significantly to understanding phytochemicals, herbal pharmacology, antioxidant mechanisms, cardiovascular protection, antimicrobial compounds, and pharmaceutical formulations. His research strengthens scientific validation of medicinal plants while encouraging interdisciplinary collaborations that bridge laboratory discoveries with practical healthcare applications and therapeutic innovations.[4]

Publications

Said Moshawih has authored numerous highly cited publications covering medicinal plants, coriander pharmacology, herbal cardiovascular benefits, antimicrobial phytochemicals, colorectal cancer prevention, pharmaceutical sciences, and evidence-based natural medicine. These publications demonstrate sustained scholarly productivity, interdisciplinary collaboration, and consistent contributions to international scientific literature.[2]

Research Impact

Said Moshawih’s research has influenced pharmaceutical sciences by providing comprehensive evidence supporting medicinal plants and natural therapeutics. His publications receive substantial academic recognition through citations, demonstrating meaningful impact on pharmacological research, healthcare innovation, systematic reviews, and future evidence-based therapeutic development internationally.[1]

Award Suitability

Said Moshawih demonstrates strong qualifications for the Best Researcher Award through impactful publications, substantial citation performance, international collaborations, and continuous advancement of pharmacological knowledge. His scientific achievements reflect excellence in research quality, innovation, scholarly influence, and contributions benefiting healthcare and pharmaceutical sciences.[1]

Conclusion

Said Moshawih continues advancing pharmacology through innovative investigations involving medicinal plants, pharmaceutical sciences, and natural products. His sustained scholarly productivity, collaborative research, and evidence-based scientific contributions reinforce his reputation as a respected researcher supporting future developments in healthcare, therapeutic innovation, and pharmaceutical research worldwide.[2]

References

  1. Elsevier. (n.d.). Scopus Author Details: Said Moshawih, Author ID 57209745538. Scopus.
    https://www.scopus.com/pages/authors/57209745538
  2. ResearchGate. (n.d.). Research Profile of Said Moshawih.
    https://www.researchgate.net/profile/Said-Moshawih
  3. ORCID. Said Moshawih Research Profile.
    https://orcid.org/0000-0003-4840-0460
  4. Google Scholar. Said Moshawih Citation Profile.
    https://scholar.google.com/citations?user=_eqg7H4AAAAJ&hl=en&oi=ao
  5. Al-Ahliyya Amman University. Faculty Profile: Said Moshawih.
    https://www.ammanu.edu.jo/staff-directory/faculty-of-pharmacy/said-moshawih/

Bina Kashyap | Oncology | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Bina Kashyap
Agartala Government Dental College, India

Bina Kashyap
Affiliation Agartala Government Dental College
Country India
Scopus ID 39561184400
Documents 28
Citations
389
h-index
11
Subject Area Oncology
Event Health Scientists Awards
ORCID 0000-0001-9192-8645

Bina Kashyap is an academic researcher affiliated with Agartala Government Dental College, India. Her scholarly work contributes to oncology-related oral health research, emphasizing clinical dentistry, oral pathology, cancer prevention, and evidence-based healthcare. Through peer-reviewed scientific publications, she has participated in advancing understanding of oral diseases associated with malignancy and related diagnostic approaches. Her research activities demonstrate continued engagement with interdisciplinary healthcare investigations and provide meaningful contributions to dental oncology literature.[1]

Abstract

Bina Kashyap has developed an academic profile centered on oncology-related oral healthcare, integrating clinical dentistry with evidence-based scientific investigation. Her published studies contribute to understanding oral manifestations associated with cancer, diagnostic evaluation, pathology, preventive strategies, and multidisciplinary patient management. Through collaboration with healthcare professionals and academic researchers, her work supports improved clinical decision-making and encourages continual advancement in dental oncology research. The consistency of her scholarly contributions, institutional affiliation, and participation in peer-reviewed scientific communication collectively demonstrate sustained professional engagement within oncology and oral health sciences, reflecting recognized standards of academic research excellence.[1][2]

Keywords

Oral Oncology, Oral Cancer, Oral Pathology, Dental Oncology, Precancerous Lesions, Oral Medicine, Clinical Dentistry, Histopathology, Cancer Diagnosis, Public Health Dentistry.

Introduction

Bina Kashyap contributes to oncology research through dental science by examining oral diseases, pathological conditions, diagnostic practices, and preventive healthcare. Her academic publications strengthen interdisciplinary collaboration between dentistry and medicine while supporting evidence-based clinical management and improved patient outcomes across oral healthcare settings.[2]

Research Profile

Bina Kashyap maintains an active scholarly profile through peer-reviewed publications indexed in international databases. Her affiliation with Agartala Government Dental College reflects continuing involvement in academic research, clinical education, and collaborative scientific activities related to oncology, oral pathology, and dental healthcare advancement.[1]

Research Contributions

Bina Kashyap has contributed to scientific understanding by investigating oral pathological conditions, cancer-related lesions, diagnostic approaches, and preventive dental practices. Her collaborative research encourages evidence-based treatment planning while supporting broader awareness regarding early detection and multidisciplinary management within oral oncology research.[3]

Publications

Bina Kashyap has authored and co-authored peer-reviewed publications addressing oral oncology, oral pathology, dental diagnostics, and associated healthcare topics. Her scholarly articles appear within recognized academic journals, contributing validated scientific evidence that supports clinical practice, education, and future interdisciplinary research developments.[2]

Research Impact

Bina Kashyap demonstrates measurable academic influence through internationally indexed publications that support evidence-based dentistry and oncology research. Her scientific output contributes valuable knowledge for clinicians, educators, and researchers while promoting continuous improvement in diagnostic accuracy, patient care, and interdisciplinary healthcare collaboration.[1]

Award Suitability

Bina Kashyap demonstrates qualifications consistent with recognition through the Innovative Research Award by maintaining scholarly productivity, contributing oncology-related dental research, encouraging collaborative scientific inquiry, and supporting clinical advancement. Her academic record reflects commitment to research quality, professional integrity, and healthcare innovation.[4]

Conclusion

Bina Kashyap represents a dedicated academic researcher whose work integrates dentistry with oncology through scientifically validated investigation. Her publications, institutional engagement, and commitment to evidence-based healthcare collectively support continued professional recognition while encouraging future advancements in oral cancer research and clinical practice.[1]

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Bina Kashyap, Author ID 39561184400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=39561184400
  2. ORCID. (n.d.). Bina Kashyap – ORCID Research Profile.
    https://orcid.org/0000-0001-9192-8645
  3. Soiniemi, L., Kanniainen, M., Suomela, E., Ramsay, S., Jäsberg, H., Kashyap, B., & Kullaa, A. M. (n.d.). Transmembrane mucin 1 is a polarity protein in the organization of apical surface microplicae in oral epithelium. https://pubmed.ncbi.nlm.nih.gov/41146464/
  4. Ramsay, S., Hyvärinen, E., Mikkonen, J., González-Arriagada, W. A., Salo, T., Lopes, M. A., Kashyap, B., & Kullaa, A. M. (n.d.). Salivary metabolite-based prediction of radiotherapy-induced oral mucositis and candidiasis. https://pubmed.ncbi.nlm.nih.gov/41372697/
  5. Kashyap, B., Naumanen, K., Mikkonen, J., Dekker, H., Schulten, E., Bloemena, E., Pasonen-Seppänen, S., & Kullaa, A. (n.d.). Irradiation alters the expression of MUC1, CD44 and hyaluronan in oral mucosal epithelium. https://doi.org/10.3390/biomedicines10112816

Chun-De Liao | Rehabilitation Science | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Chun-De Liao
Taipei Medical University, Taiwan

Chun-De Liao
Affiliation Taipei Medical University
Country Taiwan
Scopus ID 55793527000
Documents 66
Citations
2,379
h-index
25
Subject Area Rehabilitation Science
Event Health Scientists Awards
ORCID 0000-0002-1930-4915

Chun-De Liao is a rehabilitation scientist affiliated with Taipei Medical University whose scholarly work focuses on rehabilitation medicine, exercise intervention, frailty, sarcopenia, functional performance, aging, and evidence-based clinical rehabilitation. His research integrates clinical assessment with rehabilitation strategies that support healthy aging and improved physical function. These sustained contributions provide a strong academic foundation for recognition through the Innovative Research Award presented at the Health Scientists Awards.[1]

Abstract

Chun-De Liao has established an academic profile centered on rehabilitation science, functional recovery, healthy aging, frailty prevention, and therapeutic exercise interventions. His publications examine evidence-based rehabilitation strategies that improve muscle strength, mobility, physical performance, and quality of life among older adults and clinical populations. Through systematic investigations, multidisciplinary collaboration, and clinically applicable findings, his work supports healthcare professionals in designing effective rehabilitation programs. His scholarly contributions emphasize translational research, outcome measurement, and patient-centered rehabilitation while advancing scientific understanding of exercise medicine and geriatric rehabilitation across diverse healthcare environments and international academic communities.[2]

Keywords

Rehabilitation Science, Sarcopenia, Frailty, Exercise Therapy, Resistance Training, Older Adults, Physical Function, Functional Performance, Geriatric Rehabilitation, Muscle Strength, Mobility, Balance Training, Aging, Clinical Rehabilitation, Physical Activity.

Introduction

Chun-De Liao develops rehabilitation research addressing age-related functional decline through scientifically validated exercise interventions and clinical assessments. His studies strengthen evidence supporting rehabilitation professionals while encouraging healthier aging, improved independence, enhanced mobility, and better long-term outcomes across diverse patient populations in modern healthcare systems.[3]

Research Profile

Chun-De Liao maintains an internationally visible research profile emphasizing rehabilitation medicine, gerontology, therapeutic exercise, and functional evaluation. His scholarly record demonstrates continuous engagement in multidisciplinary clinical research, contributing evidence that informs rehabilitation practices and supports healthcare professionals managing musculoskeletal and age-related functional impairments effectively.[1]

Research Contributions

Chun-De Liao contributes meaningful knowledge regarding exercise prescription, frailty prevention, sarcopenia management, and rehabilitation outcomes. His investigations provide clinically relevant evidence supporting individualized rehabilitation planning, functional recovery, improved mobility, and enhanced quality of life through scientifically validated therapeutic interventions and comprehensive outcome assessments.[4]

Publications

Chun-De Liao has authored numerous peer-reviewed publications focusing on rehabilitation science, resistance exercise, aging, physical performance, frailty, and clinical rehabilitation. His publications appear in recognized scientific journals and collectively strengthen evidence-based rehabilitation practices through systematic analysis, clinical investigation, and interdisciplinary healthcare collaboration.[5]

Research Impact

Chun-De Liao generates measurable research impact by advancing rehabilitation strategies applicable to aging populations and individuals experiencing functional limitations. His scientific findings support evidence-based healthcare decision making, encourage multidisciplinary collaboration, and promote sustainable improvements in rehabilitation quality, patient mobility, and physical independence internationally.[2]

Award Suitability

Chun-De Liao demonstrates qualities associated with the Innovative Research Award through sustained scholarly productivity, clinically significant rehabilitation research, interdisciplinary collaboration, and evidence-based innovation. His contributions align with the Health Scientists Awards by advancing rehabilitation science while supporting meaningful improvements in healthcare practice and patient outcomes.[3]

Conclusion

Chun-De Liao continues strengthening rehabilitation science through clinically relevant research integrating exercise medicine, functional assessment, and healthy aging. His scholarly achievements reflect consistent scientific excellence, making his research profile well aligned with recognition through the Innovative Research Award presented during the Health Scientists Awards.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Chun-De Liao, Author ID 55793527000. Scopus.https://www.scopus.com/pages/authors/55793527000
  2. Liao, C.-D. (n.d.). Chun-De Liao. Taipei Medical University.https://hub.tmu.edu.tw/en/persons/chun-de-liao/
  3. ORCID. (n.d.). Chun-De Liao ORCID Record.https://orcid.org/0000-0002-1930-4915
  4. Google Scholar. (n.d.). Publication and Citation Profile of Chun-De Liao.https://scholar.google.com/citations?user=iM_rCJ0AAAAJ&hl=en&oi=ao
  5. Health Scientists Awards. (n.d.). Innovative Research Award.https://healthscientists.org/